Case Report
Published on 24 Dec 2024
Neoadjuvant immunotherapy plus chemotherapy for squamous cell carcinoma of the paranasal sinus: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1462993
- 102 views
Type at least 3 characters
1,350 articles
Articles
Case Report
Published on 24 Dec 2024
Case report: Aggressive NSCLC with partial BRG-1 deficiency and KRAS G12C mutation: a case study and treatment challenges
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1515240
- 126 views
Review
Accepted on 23 Dec 2024
Innovative Applications and Future Trends of Multiparametric PET in the Assessment of Immunotherapy Efficacy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1530507
Systematic Review
Published on 23 Dec 2024
Prognostic significance of systemic immune inflammation index in patients with urothelial carcinoma: a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1469444
- 179 views
Mini Review
Accepted on 20 Dec 2024
Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1502270
Mini Review
Accepted on 20 Dec 2024
Advanced progress in the genetic modification of the oncolytic HSV-1 virus
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1525940
Review
Accepted on 20 Dec 2024
Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1531219
Review
Published on 20 Dec 2024
10 years of BiTE immunotherapy: an overview with a focus on pancreatic cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1429330
- 324 views
Case Report
Published on 20 Dec 2024
Successful treatment of recurrent refractory Kaposi’s sarcoma in AIDS: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1462381
- 202 views
Original Research
Accepted on 19 Dec 2024
Multiomic analysis of lactylation and mitochondria-related genes in hepatocellular carcinoma identified MRPL3 as a new prognostic biomarker
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1511958
- 121 views
Original Research
Accepted on 19 Dec 2024
CA19-9-related macrophage polarization drives poor prognosis in HCC after immune checkpoint inhibitor treatment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1528138
Original Research
Published on 19 Dec 2024
Gut virome dysbiosis impairs antitumor immunity and reduces 5-fluorouracil treatment efficacy for colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1501981
- 139 views
Original Research
Published on 17 Dec 2024
Cost-effectiveness analysis of anlotinib plus chemotherapy with or without benmelstobart versus chemotherapy alone for extensive-stage small-cell lung cancer in China
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1484650
- 205 views
Original Research
Published on 17 Dec 2024
The establishment of PD-1 inhibitor treatment prognosis model based on dynamic changes of peripheral blood indexes in patients with advanced lung squamous cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1454709
- 229 views
Original Research
Accepted on 16 Dec 2024
DET induces apoptosis and suppresses tumor invasion in glioma cells via PI3K/AKT pathway
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1528454
Case Report
Accepted on 16 Dec 2024
Long-Term Disease Control in Dedifferentiated Liposarcoma: A Case Report on Trabectedin Priming Followed by PD-1 Inhibition
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1518775